Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients

le Ishitobi, Makoto, Shibuya, Kazuyo, Komoike, Yoshifumi, Koyama, Hiroki, Inaji, Hideo
Foilsithe 2013

The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer

le YAMAMURA, JUN, KAMIGAKI, SHUNJI, FUJITA, JUNYA, OSATO, HIROKI, KOMOIKE, YOSHIFUMI
Foilsithe in In Vivo (2018)

Regression of brain metastases from breast cancer with eribulin: a case report

le Matsuoka, Hiromichi, Tsurutani, Junji, Tanizaki, Junko, Iwasa, Tsutomu, Komoike, Yoshifumi, Koyama, Atsuko, Nakagawa, Kazuhiko
Foilsithe 2013

O(6)-methylguanine-DNA methyltransferase as a prognostic and predictive marker for basal-like breast cancer treated with cyclophosphamide-based chemotherapy

le ISONO, SAYURI, FUJISHIMA, MAKOTO, AZUMI, TATSUYA, HASHIMOTO, YUKIHIKO, KOMOIKE, YOSHIFUMI, YUKAWA, MASAO, WATATANI, MASAHIRO
Foilsithe 2014

HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive meta...

le Sakai, Hitomi, Tsurutani, Junji, Iwasa, Tsutomu, Komoike, Yoshifumi, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Foilsithe in Breast Cancer (2018)

Carcinosarcoma of the breast: A case of breast conservation surgery and breast reconstruction

le Kanaizumi, Hirofumi, Higashi, Chihiro, Tanaka, Yumiko, Hamada, Mika, Shinzaki, Wataru, Hashimoto, Yukihiko, Komoike, Yoshifumi
Foilsithe in SAGE Open Med Case Rep (2019)

One-step nucleic acid amplification assay for intraoperative prediction of advanced axillary lymph node metastases in breast cancer patients with sentinel lymph node metastasis

le KUBOTA, MICHIYO, KOMOIKE, YOSHIFUMI, HAMADA, MIKA, SHINZAKI, WATARU, AZUMI, TATSUYA, HASHIMOTO, YUKIHIKO, IMOTO, SHIGERU, TAKEYAMA, YOSHIFUMI, OKUNO, KIYOTAKA
Foilsithe in Mol Clin Oncol (2016)

New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patien...

le Yamamura, Jun, Kamigaki, Shunji, Fujita, Junya, Osato, Hiroki, Manabe, Hironobu, Tanaka, Yumiko, Shinzaki, Wataru, Hashimoto, Yukihiko, Komoike, Yoshifumi
Foilsithe in BMC Cancer (2021)

PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy

le Kanaizumi, Hirofumi, Higashi, Chihiro, Tanaka, Yumiko, Hamada, Mika, Shinzaki, Wataru, Azumi, Tatsuya, Hashimoto, Yukihiko, Inui, Hiroki, Houjou, Toshiya, Komoike, Yoshifumi
Foilsithe in Oncol Lett (2019)

Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement

le Nagashima, Yukiko, Yoshino, Shigehumi, Yamamoto, Shigeru, Maeda, Noriko, Azumi, Tatsuya, Komoike, Yoshifumi, Okuno, Kiyotaka, Iwasa, Tsutomu, Tsurutani, Junji, Nakagawa, Kazuhiko, Masaaki, Oka, Hiroaki, Nagano
Foilsithe in Mol Clin Oncol (2017)

Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study

le YAMAMURA, JUN, KAMIGAKI, SHUNJI, TSUJIE, MASAKI, FUJITA, JUNYA, OSATO, HIROKI, HIGASHI, CHIHIRO, KANAIZUMI, HIROFUMI, TANAKA, YUMIKO, HAMADA, MIKA, SHINZAKI, WATARU, HASHIMOTO, YUKIHIKO, KOMOIKE, YOSHIFUMI
Foilsithe in In Vivo (2019)

Case report: schwannoma arising from the unilateral adrenal area with bilateral hyperaldosteronism

le Babaya, Naru, Makutani, Yukako, Noso, Shinsuke, Hiromine, Yoshihisa, Ito, Hiroyuki, Taketomo, Yasunori, Ueda, Kazuki, Ushijima, Hokuto, Komoike, Yoshifumi, Yamazaki, Yuto, Sasano, Hironobu, Kawabata, Yumiko, Ikegami, Hiroshi
Foilsithe in BMC Endocr Disord (2017)

Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases

le OKITA, YOSHIKO, NARITA, YOSHITAKA, SUZUKI, TSUYOSHI, ARITA, HIDEYUKI, YONEMORI, KAN, KINOSHITA, TAKAYUKI, FUJIWARA, YASUHIRO, TSUDA, HITOSHI, KOMOIKE, YOSHIFUMI, NAKAGAWA, HIDEMITSU, TAMAKI, YASUHIRO, TOMITA, YASUHIKO, SHIBUI, SOICHIRO, MARUNO, MOTOHIKO
Foilsithe 2013

Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer

le Tsurutani, Junji, Kuroi, Katsumasa, Iwasa, Tsutomu, Miyazaki, Masaki, Nishina, Shinichi, Makimura, Chihiro, Tanizaki, Junko, Okamoto, Kunio, Yamashita, Toshinari, Aruga, Tomoyuki, Shigekawa, Takashi, Komoike, Yoshifumi, Saeki, Toshiaki, Nakagawa, Kazuhiko
Foilsithe in Cancer Sci (2015)

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence

le Shien, Tadahiko, Tanaka, Takehiro, Tanabe, Masahiko, Okumura, Yasuhiro, Masuda, Norikazu, Yoshida, Atsushi, Arima, Nobuyuki, Komoike, Yoshifumi, Tanaka, Satoru, Iwase, Takuji, Taguchi, Tetsuya, Nakatsukasa, Katsuhiko, Inaji, Hideo, Ishitobi, Makoto
Foilsithe in Oncol Lett (2017)

Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid

le Yanae, Masashi, Fujimoto, Shinichiro, Tane, Kaori, Tanioka, Maki, Fujiwara, Kimiko, Tsubaki, Masanobu, Yamazoe, Yuzuru, Morishima, Yoshiyuki, Chiba, Yasutaka, Takao, Shintaro, Komoike, Yoshifumi, Tsurutani, Junji, Nakagawa, Kazuhiko, Nishida, Shozo
Foilsithe in J Bone Oncol (2017)

Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case–control study in Japanese women

le Mizoo, Taeko, Taira, Naruto, Nishiyama, Keiko, Nogami, Tomohiro, Iwamoto, Takayuki, Motoki, Takayuki, Shien, Tadahiko, Matsuoka, Junji, Doihara, Hiroyoshi, Ishihara, Setsuko, Kawai, Hiroshi, Kawasaki, Kensuke, Ishibe, Youichi, Ogasawara, Yutaka, Komoike, Yoshifumi, Miyoshi, Shinichiro
Foilsithe 2013

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

le Iwasa, Tsutomu, Tsurutani, Junji, Watanabe, Satomi, Kato, Ryoji, Mizuno, Yutaka, Kojima, Yasuyuki, Takashima, Tsutomu, Matsunami, Nobuki, Morimoto, Takashi, Yamamura, Jun, Ohtani, Shoichiro, Tanabe, Yuko, Yoshinami, Tetsuhiro, Takano, Toshimi, Komoike, Yoshifumi, Nakagawa, Kazuhiko
Foilsithe in BMC Cancer (2019)

The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMA...

le Takahashi, Masato, Ohtani, Shoichiro, Nagai, Shigenori E., Takashima, Seiki, Yamaguchi, Miki, Tsuneizumi, Michiko, Komoike, Yoshifumi, Osako, Tomofumi, Ito, Yoshinori, Ikeda, Masahiko, Ishida, Kazushige, Nakayama, Takahiro, Takashima, Tsutomu, Asakawa, Takashi, Matsumoto, Sho, Shimizu, Daisuke, Masuda, Norikazu
Foilsithe in Breast Cancer Res Treat (2020)